Your browser doesn't support javascript.
loading
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.
Reap, Elizabeth A; Suryadevara, Carter M; Batich, Kristen A; Sanchez-Perez, Luis; Archer, Gary E; Schmittling, Robert J; Norberg, Pamela K; Herndon, James E; Healy, Patrick; Congdon, Kendra L; Gedeon, Patrick C; Campbell, Olivia C; Swartz, Adam M; Riccione, Katherine A; Yi, John S; Hossain-Ibrahim, Mohammed K; Saraswathula, Anirudh; Nair, Smita K; Dunn-Pirio, Anastasie M; Broome, Taylor M; Weinhold, Kent J; Desjardins, Annick; Vlahovic, Gordana; McLendon, Roger E; Friedman, Allan H; Friedman, Henry S; Bigner, Darell D; Fecci, Peter E; Mitchell, Duane A; Sampson, John H.
Afiliación
  • Reap EA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Suryadevara CM; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • Batich KA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Sanchez-Perez L; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • Archer GE; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Schmittling RJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Norberg PK; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • Herndon JE; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Healy P; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Congdon KL; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • Gedeon PC; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Campbell OC; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • Swartz AM; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Riccione KA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Yi JS; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • Hossain-Ibrahim MK; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Saraswathula A; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • Nair SK; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina.
  • Dunn-Pirio AM; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina.
  • Broome TM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Weinhold KJ; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • Desjardins A; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Vlahovic G; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • McLendon RE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Friedman AH; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • Friedman HS; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Bigner DD; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • Fecci PE; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Mitchell DA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Sampson JH; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
Cancer Res ; 78(1): 256-264, 2018 01 01.
Article en En | MEDLINE | ID: mdl-29093005
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Neoplasias Encefálicas / Linfocitos T / Inmunoterapia Adoptiva / Glioblastoma Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Neoplasias Encefálicas / Linfocitos T / Inmunoterapia Adoptiva / Glioblastoma Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Año: 2018 Tipo del documento: Article